Study Identifies Dynamic Gating Mechanism in Amino Acid Transporter b0,+AT
Researchers using molecular dynamics simulations have identified a single amino acid residue, W230, that acts as a dynamic gate controlling arginine entry into the b0,+AT transporter protein. The study found that arginine binding at a separate site (V186) triggers a signaling cascade through transmembrane helices that causes W230's side chain to flip, opening the transport channel. These findings could inform understanding of diseases linked to defective amino acid transport, such as cystinuria.
Using conventional and adaptive steered molecular dynamics (cMD and ASMD) simulations, the researchers mapped how arginine moves through the b0,+AT transporter, a member of the heteromeric amino acid transporter (HAT) family responsible for essential amino acid flux across cell membranes. The key finding is that residue W230 functions as a dynamic gate: its side chain physically reorients to allow or restrict arginine passage through the channel. This gating is not autonomous — arginine binding at residue V186 initiates a regulatory signal that propagates through transmembrane helix 5 (TM5), a connecting loop, and TM6 before reaching W230. Dynamic network analysis and dynamical cross-correlation of residue motions were used to trace this allosteric communication pathway. The authors propose that this residue-triggered side chain reorientation may represent a conserved mechanistic strategy across transporter proteins more broadly, not just in b0,+AT. The work provides a detailed mechanistic model for b0,+AT-mediated transport at atomic resolution, advancing understanding of how HAT family members regulate substrate translocation.
What's missing
The study is a computational preprint and has not yet been peer-reviewed. Key limitations include the absence of experimental validation (e.g., mutagenesis studies or structural data such as cryo-EM) confirming the functional role of W230 and the proposed signaling pathway in vitro or in vivo. The generalizability of the proposed conserved gating mechanism to other HAT family members also remains to be tested empirically.
What different sources said
- bioRxivCenter
Dynamic Gating Mechanism of the b0,+AT-Mediated Arg Transport: Insights from ASMD Simulations
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.